Summary A 6-month exposure of ZR-75-1 human breast cancer cells to tamoxifen (1 UM rising to 2 PM), resulted in a fall in oestrogen receptor (ER) levels from 225 fmol mg protein-1 to 56 fmol mg protein-1 while progesterone receptor (PGR) concentration fell from 63 fmol mg protein-1 to undetectable levels. Sensitivity to the anti-proliferative effects of tamoxifen was unchanged. A further 6 months' exposure to 4 MM tamoxifen resulted in loss of detectable ER and PGR and development of resistance to tamoxifen. Resistant al., 1978). A large subset of ER-positive tumours therefore do not respond, and patients may also relapse following an initial response to the anti-oestrogen. Paradoxically, patients resistant to tamoxifen may respond to alternative hormonal therapy and among patients acquiring 'resistance' to tamoxifen some may show a further response on subsequent re-challenge with the drug.
The anti-oestrogen tamoxifen is of proven value in the treatment of advanced breast cancer in post-menopausal women with approximately 50% of oestrogen receptor (ER) positive tumours showing a response to therapy (Mouridsen et al., 1978) . A large subset of ER-positive tumours therefore do not respond, and patients may also relapse following an initial response to the anti-oestrogen. Paradoxically, patients resistant to tamoxifen may respond to alternative hormonal therapy and among patients acquiring 'resistance' to tamoxifen some may show a further response on subsequent re-challenge with the drug.
The availability of a number of cell lines derived from human breast cancer has greatly aided studies on the mechanism of oestrogen control of breast cancer cell proliferation and its inhibition by anti-oestrogens. The development of anti-oestrogen resistant variants from such lines should provide further insight into the mechanism of action of and development of resistance to anti-oestrogens. The majority of studies to date have shown that resistance is not associated with the acquisition of an ER-negative phenotype. Thus both the R3 (Nawata et al., 1981b) and R27 (Nawata et al., 1981a) tamoxifen-resistant sub-lines derived from MCF-7 retain ER, although they differ in a number of responses to.oestrogen stimulation. Neither of these lines, however, maintains the resistant phenotype in the absence of continuing tamoxifen exposure (Bronzert et al., 1986) . LY2, an MCF-7 variant, was selected for its ability to grow in the presence of the potent anti-oestrogen LY 117018, and is cross-resistant to tamoxifen. This line also expresses ER, although to a lesser extent than MCF-7, and seems to be stably resistant to anti-oestrogens (Bronzert et al., 1985) . A tamoxifen and oestrogen insensitive variant of the T47D line, lacking ER but expressing high levels of progesterone receptor (PGR), has also been described but this line arose as a result of changes in culture conditions rather than under selective pressure of anti-oestrogen exposure (Horwitz et al., 1982) .
In this paper we describe what is, to our knowledge, the first tamoxifen-resistant variant of the ZR-75-1 human breast cancer cell line. This variant arose during prolonged Correspondence: H.W. van den Berg. Received 22 September 1988, and in revised form, 22 October 1988. exposure of the parent line to increasing concentrations of tamoxifen and appears to represent a novel resistant phenotype having lost both ER and PGR. We also describe ultrastructural characteristics of this variant and report on phenotypic stability in the absence of continuing selective pressure.
Materials and methods
Cell culture and development of the ZR-75-9a1 subline The ZR-75-1 human breast cancer cell line was obtained from Flow Laboratories (Irvine, Scotland) and is well characterised (Engel et al., 1978) . Cells were routinely maintained in RPMI 1640 medium supplemented with 5% fetal calf serum, 100IUml-1 penicillin and 100 igml-l streptomycin and grown in an air:CO2 atmosphere at 37°C.
In February 1985 a semi-confluent flask of ZR-75-1 cells was exposed to 1 M tamoxifen and routinely subcultured in medium containing this concentration of drug for one month. The tamoxifen concentration was then raised to 2pM for a further 6 months at which time the concentration was doubled again to 4 pM. During this period tamoxifen exposed cells were subcultured once weekly at a split ratio of 1:3, whilst the parent line was subcultured twice weekly. ER and PGR receptor expression was assessed regularly during this period and during the following year, at which time the electron microscopic studies were performed. ER and PGR were determined using a whole cell binding assay as previously described (van den Berg et al., 1987) . Tamoxifen was withdrawn from cells for three days before determining receptor expression. In certain experiments cells were transferred to RPMI medium devoid of the weakly oestrogenic pH indicator phenol red (Berthois et al., 1986) and supplemented with 5% fetal calf serum stripped of endogenous steroids using dextran coated charcoal (FCSdcc). The sensitivity of tamoxifen exposed cells, designated ZR-75-9a 1, to re-exposure to the drug was compared to that of the parent line by assessing cell numbers following 6 days' continuous treatment (van den Berg et al., 1987) . Flow cytometric studies were carried out in early 1988, at which time ZR-75-9al cells had been routinely maintained in 8pM tamoxifen for 4 months. Br. J. Cancer (1989), 59, 522-526 Electron microscopy Cells were processed for electron microscopy using a modification of the method of Pentz et al. (1983) . Briefly, cells were grown in test chambers, TCSC-1 (Pentz et al., 1981) , and exposed to 3% gluteraldehyde in 0.1 M sodium cacodylate buffer, pH 7.2-7.4. Cells were then post-fixed in 1% osmium tetroxide in 0.1 M sodium cacodylate buffer for 1 h then dehydrated through a series of ethanols (70% to absolute) and propylene oxide before embedding in Epon 812 substitute resin. Application of this procedure resulted in a resin-resin boundary region which represented the original site of cell growth. Sections of silver-gold interference colours were cut on a Reichert OMU2 ultramicrotome, lifted on copper support grids and stained with ethanolic uranyl acetate and Reynolds lead citrate.
Transmission electron micrographs were taken using a Joel 100 CX2 transmission electron microscope. Cells were prepared for scanning microscopy by growing them in multiwell dishes containing therminox plastic cover slips and fixing at 4°C for 30min in a solution of 3% gluteraldehyde/ 1% osmium tetroxide dissolved in distilled water. Cells were then washed in distilled water dehydrated through alcohols, critical point dried, mounted and coated with gold/ palladium. Scanning electron micrographs were taken using a Joel 35CF scanning electron microscope.
Flow cytometry
Cells were removed from semi-confluent 75 cm2 flasks by trypsinisation and suspended in complete growth medium. Cells were pelleted by centrifugation and resuspended in 0.02% EDTA in phosphate-buffered saline (PBS) at a concentration of 106 ml-1. Ten minutes later cells were centrifuged again, resuspended in the same volume of PBS and passed through successively smaller gauge syringe needles. Absolute ethanol was then added dropwise to a final concentration of 70% and cells fixed for 1 h at 4°C. with the doubling time extending to approximately 160 h. Under these circumstances 10-9 M oestradiol (E2) is markedly growth stimulatory (Figure 1 inset), as previously reported (Glover et al., 1988) . As expected, transfer of ZR-75-9al cells to phenol red free medium had no effect on growth rate, which was also unaffected by E2 treatment. Under phase contrast microscopy ZR-75-9al cells appeared smaller and more rounded than the parent line (Figures 2a and b) and also failed to reach full confluence, tending to grow in 'islands'. Transmission electron microscopy of the parent line revealed many of the features originally described (Engel et al., 1978) , including large irregular nuclei, saturated lipid inclusion bodies, tonofilaments, desmosomes and microvilli-lined intracellular vacuoles (Figure 3a) . ZR-75-9al cells, however, contained very little lipid, tonofilaments and desmosomes have not been observed and the nuclear:cytoplasmic ratio appeared larger than that of the parent line (Figure 3b ). Scanning electron miroscopy revealed a marked reduction in the density of surface microvilli in the ZR-75-9al line compared to ZR-75-1 (Figures 4a and b) . Table II demonstrates that a 5-day exposure of ZR-75-1 cells to 8 iM tamoxifen results in an accumulation of cells in the GO/GI phase of the cell cycle with a corresponding fall in the proportion of cells in S and G2/M. In contrast, ZR-75-9al cells routinely maintained in medium containing the same concentration of the anti-oestrogen had a virtually identical cell cycle profile to the untreated parent line.
If ZR-75-9al cells are transferred to drug-free 'complete' medium (containing phenol red and serum associated oestrogen), both ER and PGR are detectable within 4 weeks and basal PGR levels can be induced further during a 5-day exposure to 10-9 M oestradiol (Table III) . This return to receptor positivity was associated with a return to sensitivity to tamoxifen although the appearance of cells under phase (Figure 1 ). The (Nawata et al., 1981a,b (O'Brian et al., 1985 , confirming its oestrogenic activity in this respect (Vic et al., 1982) . Our observation that prolonged exposure to antioestrogens reduces microvilli density in ZR-75-1 cells would be consistent with these earlier observations.
Our flow cytometric studies on ZR-75-1 cells (Table II) confirm previous observations using the MCF-7 line that tamoxifen treatment results in an accumulation of cells in the GO/GI phase of the cell cycle (Sutherland et al., 1983 (Allegra et al., 1980; Taylor et al., 1982; Nomura et al., 1985 
